StemRIM

2026/08/21 Updated
Market Cap: $141.1M (¥22.4B)
Stock Price: $2.25 (¥358)
Exchange Rate: 1 USD = ¥158.98

Notice of Patent Registration (Australia) for Regenesis-Inducing Drug Redasemtide (HMGB1 Fragment Peptide) for Chondral Disorders

Importance:
Page Updated: June 17, 2026
IR Disclosure Date: June 17, 2026
その他

G-ステムリム

Company overview · Stock price · Financial data · All IR

View company page →